In this book, Murphy brings together a team of international experts to review cutting-edge scientific literature from the field of psychobiology and related disciplines which addresses important questions and broadens our understanding of substance use behaviours.
The reader is introduced to the multi-faceted nature of substance use and misuse, and its growing need to be discussed across diverse disciplines and perspectives. The book also addresses important questions regarding public policy and professional practice in the context of different social and cultural environments, and comments on the methodological and ethical issues in substance use and misuse. Chapters explore a spectrum of substances, which include: cocaine, alcohol, ecstasy (MDMA), methamphetamine, synthetic cannabinoids, tobacco, ketamine, novel psychoactive substances, and vaping products. The use of these substances poses important questions for science and for society. This book is written to help academics, practitioners, and students in a variety of academic and professional disciplines answer those questions while staying up to date with the psychobiological literature.
This is a vital resource for professionals and upper-level undergraduate and postgraduate students undertaking research in areas related to biological psychology, biology, health studies, and medicine.
Table of Contents
List of contributors
- The Psychobiology of Substance Use Behaviours and its Relationship to Personal and Social Psychological Interpretations of these Behaviours
- Psychobiological Aspects of Cocaine Dependence: Implications for Prevention, Treatment, and the Consequences of Use
- The Neurobiological Implications of Early Onset Excessive Alcohol Use: Potential Consequences for Psychological Functioning
- Zebrafish Models of Drug Addiction
- The Neurobiological Mechanisms Underpinning MDMA and Impaired Psychological Functioning: A Review of Studies with Human Participants
- Methamphetamine Use Disorder: Structural and Functional Implications as Shown by Brain Imaging Studies
- Synthetic Cannabinoids (SCs): Current Knowledge, Psychobiology and Clinical Applications
- Feelings of Well-being: The Contributions of Alcohol and Tobacco in Employed Workers and Students
- The Psychobiological Implications of Ketamine Misuse
- Is there Evidence of a Genetic Basis for Substance Use Disorders?
- Psychobiological; Medical; and Psychiatric Implications of New/Novel Psychoactive Substance (NPS) Use
- ‘Ecstasy’ (MDMA) and Visusospatial Processing: A follow-up Systematic Review
- The Psychobiology of Nicotine Vaping: Impact on Addiction, Cognition, Mood, Anxiety and Appetite
Philip N. Murphy, Serge Combaluzier, Derek Heim and Rebecca Monk
Mieke H. J. Schulte, Wim, van den Brink, and Reinout W. Wiers
Susan Schenk, Gabriel D. Bosse and Randall T. Peterson
Catharine Montgomery and Carl Alexander Roberts
Samantha Brooks, Kate Cockcroft and Helgi B. Schiöth
Koby Cohen and Aviv M. Weinstein
Andrew P. Smith
Fabrizio Schifano, Stefania Chiappini, Valeria Catalani, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Amira Guirguis, Alessandro Emiliano Vento, Stefania Bonaccorso and John Martin Corkery
Philip N. Murphy, Ida Ryland, Felicity Wolohan & Janice Bartholomew
Harry Tattan-Birch and Lion Shahab
Philip N. Murphy, PhD is Professor of Psychology at Edge Hill University in Lancashire, UK. He has worked professionally in addiction and substance use since 1984 and has done extensive research in the areas of opiate dependence, and the impairment of cognitive functioning related to the use of ecstasy (MDMA) and cannabis. He is also the editor of the Routledge International Handbook of Psychobiology, published in 2018.